AZD6234
SELENE-Asia
AstraZeneca · Phase 3 · Not yet recruiting · Enrollment 330
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
AZD6234
AstraZeneca · Phase 3 · Not yet recruiting · Enrollment 330
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.